AF
MRK icon

Arrow Financial’s Merck MRK Stock Holding History

Arrow Financial’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$838K Sell
6,965
-30
-0.4% -$3.46K 0.08% 106
2025
Q4 		$736K Buy
6,995
+10
+0.1% +$939 0.07% 111
2025
Q3 		$586K Sell
6,985
-3,232
-32% -$266K 0.06% 117
2025
Q2 		$809K Buy
10,217
+341
+3% +$27.1K 0.09% 104
2025
Q1 		$886K Sell
9,876
-245
-2% -$22.9K 0.1% 102
2024
Q4 		$1.01M Sell
10,121
-125
-1% -$12.9K 0.1% 108
2024
Q3 		$1.16M Sell
10,246
-35
-0.3% -$4.16K 0.11% 102
2024
Q2 		$1.27M Buy
10,281
+1,835
+22% +$236K 0.12% 95
2024
Q1 		$1.11M Sell
8,446
-33
-0.4% -$4.07K 0.11% 104
2023
Q4 		$924K Sell
8,479
-534
-6% -$55.4K 0.1% 109
2023
Q3 		$928K Sell
9,013
-63
-0.7% -$6.79K 0.11% 102
2023
Q2 		$1.05M Sell
9,076
-596
-6% -$67.7K 0.13% 100
2023
Q1 		$1.03M Sell
9,672
-221
-2% -$23.9K 0.13% 104
2022
Q4 		$1.1M Sell
9,893
-415
-4% -$42.4K 0.15% 99
2022
Q3 		$888K Hold
10,308
– – 0.13% 105
2022
Q2 		$940K Sell
10,308
-620
-6% -$55K 0.13% 104
2022
Q1 		$897K Sell
10,928
-315
-3% -$24.8K 0.11% 112
2021
Q4 		$861K Sell
11,243
-6,090
-35% -$485K 0.1% 112
2021
Q3 		$1.3M Sell
17,333
-32,914
-66% -$2.5M 0.17% 90
2021
Q2 		$3.91M Sell
50,247
-11,657
-19% -$867K 0.5% 45
2021
Q1 		$4.55M Buy
61,904
+522
+0.9% +$38.5K 0.6% 39
2020
Q4 		$4.79M Sell
61,382
-198
-0.3% -$15.1K 0.93% 30
2020
Q3 		$4.87M Sell
61,580
-554
-0.9% -$43.4K 1.03% 29
2020
Q2 		$4.58M Sell
62,134
-367
-0.6% -$27.6K 1% 27
2020
Q1 		$4.59M Buy
62,501
+264
+0.4% +$20.7K 1.09% 21
2019
Q4 		$5.4M Sell
62,237
-2,927
-4% -$240K 1.05% 22
2019
Q3 		$5.24M Sell
65,164
-1,656
-2% -$133K 1.09% 21
2019
Q2 		$5.35M Sell
66,820
-1,838
-3% -$141K 1.15% 22
2019
Q1 		$5.45M Sell
68,658
-665
-1% -$49.7K 1.26% 18
2018
Q4 		$5.05M Buy
69,323
+5
+0% +$353 1.29% 19
2018
Q3 		$4.69M Buy
69,318
+1,333
+2% +$84.9K 0.99% 25
2018
Q2 		$3.94M Sell
67,985
-6,561
-9% -$370K 0.88% 30
2018
Q1 		$3.88M Sell
74,546
-890
-1% -$48.1K 0.9% 30
2017
Q4 		$4.05M Sell
75,436
-760
-1% -$42.1K 0.94% 28
2017
Q3 		$4.66M Sell
76,196
-392
-0.5% -$23.8K 1.1% 23
2017
Q2 		$4.68M Sell
76,588
-1,777
-2% -$108K 1.12% 20
2017
Q1 		$4.75M Sell
78,365
-307
-0.4% -$18.6K 1.16% 20
2016
Q4 		$4.42M Sell
78,672
-234
-0.3% -$13.7K 1.1% 22
2016
Q3 		$4.7M Sell
78,906
-3,259
-4% -$191K 1.19% 19
2016
Q2 		$4.52M Buy
82,165
+404
+0.5% +$21.5K 1.18% 22
2016
Q1 		$4.13M Buy
81,761
+1,023
+1% +$50.1K 1.1% 27
2015
Q4 		$4.07M Buy
80,738
+11,727
+17% +$591K 1.09% 27
2015
Q3 		$3.25M Buy
69,011
+823
+1% +$43.7K 0.92% 33
2015
Q2 		$3.7M Buy
68,188
+3,895
+6% +$218K 1% 31
2015
Q1 		$3.53M Buy
64,293
+3,203
+5% +$181K 0.95% 33
2014
Q4 		$3.31M Sell
61,090
-118
-0.2% -$6.57K 0.9% 34
2014
Q3 		$3.46M Buy
61,208
+2,205
+4% +$124K 0.96% 26
2014
Q2 		$3.26M Buy
59,003
+241
+0.4% +$13.1K 0.88% 29
2014
Q1 		$3.18M Buy
58,762
+692
+1% +$35.8K 0.9% 26
2013
Q4 		$2.77M Sell
58,070
-13,246
-19% -$605K 0.8% 34
2013
Q3 		$3.24M Buy
71,316
+978
+1% +$44.7K 0.99% 24
2013
Q2 		$3.12M Buy
+70,338
New +$3.14M 1% 28

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrow Financial's MRK Position: Q1 2026 in Review

Arrow Financial reduced its Merck (MRK) stake by 0.43% in Q1 2026, selling an estimated $3.46K and leaving 6,965 shares worth $838K. The position accounts for 0.08% of the portfolio, ranked #106.

Arrow Financial first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.45M in Q1 2019. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Arrow Financial held 6,965 shares of Merck worth $838K as of Q1 2026.
  • Arrow Financial sold 30 Merck shares in Q1 2026, an estimated $3.46K.
  • Merck made up 0.08% of Arrow Financial's portfolio in Q1 2026, its #106 holding.
  • Arrow Financial first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Arrow Financial's Merck position peaked at $5.45M in Q1 2019.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Arrow Financial's 13F filing for Q1 2026, filed 11 May 2026.